NCT07782619

Brief Summary

The purpose of this study is to compare the measurements obtained with two different biometers, UNITY Dx and Anterion. In eye care, a biometer is a device that uses laser technology to take highly precise measurements of the eye's internal structures. It is most frequently used to help determine the exact power of the intraocular lens (IOL) needed before cataract removal.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
4mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Aug 2026Jan 2027

Study Start

First participant enrolled

August 1, 2026

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

August 20, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 24, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

August 24, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

August 20, 2026

Last Update Submit

August 20, 2026

Conditions

Keywords

Biometer

Outcome Measures

Primary Outcomes (1)

  • Regression-Based Axial Length (R-AL)

    Regression-based Axial Length (R-AL) is the distance from the anterior surface of the cornea to the retina at the back of the eye, measured along the visual axis. R-AL will be measured by the device and reported in microns.

    Day 1

Study Arms (5)

Normal Corneas

This cohort will enroll subjects with normal corneas.

Device: UNITY DXDevice: ANTERION

Keratoconus

This cohort will enroll subjects with keratoconus.

Device: UNITY DXDevice: ANTERION

Prior Corneal Laser Vision Correction

This cohort will enroll subjects with prior corneal laser vision correction.

Device: UNITY DXDevice: ANTERION

Current and Habitual Contact Lens Wear

This cohort will enroll subjects with current and habitual contact lens wear.

Device: UNITY DXDevice: ANTERION

Dry Eye

This cohort will enroll subjects with dry eye.

Device: UNITY DXDevice: ANTERION

Interventions

UNITY DXDEVICE

Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

Current and Habitual Contact Lens WearDry EyeKeratoconusNormal CorneasPrior Corneal Laser Vision Correction
ANTERIONDEVICE

Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

Current and Habitual Contact Lens WearDry EyeKeratoconusNormal CorneasPrior Corneal Laser Vision Correction

Eligibility Criteria

Age21 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cohorts will be selected from approximately one investigative site located in the United States.

You may qualify if:

  • Have healthy, clear corneas for the normal cohort;
  • Have documented keratoconus for the keratoconus cohort;
  • Have reported use of daily contact lens use for the contact lens cohort;
  • Have documented dry eye, consisting of signs and symptoms for the dry eye cohort;
  • Has had previous keratorefractive surgery for the post-refractive surgery cohort;
  • Able to comprehend and sign the informed consent form.

You may not qualify if:

  • Active ocular infection or inflammation;
  • Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus);
  • Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study result or may interfere significantly with the subject's participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Eye Institute of Utah

Salt Lake City, Utah, 84107, United States

Location

Study Officials

  • Clinical Trial Lead, Surgical

    Alcon Research, LLC

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 20, 2026

First Posted

August 24, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Last Updated

August 24, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations